| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/31/2001 | DE10056747A1 New nucleic acid sequences from a human immune deficiency virus intersubtype, useful for treatment, prevention and diagnosis of infection |
| 05/31/2001 | CA2762106A1 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 05/31/2001 | CA2429394A1 Method of inducing immune tolerance |
| 05/31/2001 | CA2422429A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | CA2393322A1 Method of proliferating natural killer cells |
| 05/31/2001 | CA2393126A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392387A1 Polypeptides and methods for thymic vaccination |
| 05/31/2001 | CA2392375A1 Synthetic oligomannosides, preparation and uses thereof |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392235A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | CA2391943A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 05/31/2001 | CA2391499A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | CA2391434A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | CA2390802A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2390344A1 85kda neisserial antigen |
| 05/31/2001 | CA2389537A1 Mixture of pomegranate seed oil and juice products |
| 05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 05/30/2001 | EP1103614A1 Novel plasmid vector |
| 05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
| 05/30/2001 | EP1103602A1 New lymphocytes, a process for preparing the same and their use, in therapeutics |
| 05/30/2001 | EP1103564A1 Cancer antigens based on tumor suppressor gene wt1 product |
| 05/30/2001 | EP1103268A1 Use of staphylococcal enterotoxins or related compounds for cancer treatment by infusion |
| 05/30/2001 | EP1103265A1 T-cells specific for polymorphic proteins on malignant cells |
| 05/30/2001 | EP1102853A1 N-acetylglycosaminyltransferase genes |
| 05/30/2001 | EP1102850A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 05/30/2001 | EP1102848A2 Molecules designated ldcam |
| 05/30/2001 | EP1102838A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP1102600A2 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297482A Group B streptococcus antigens |
| 05/30/2001 | CN1297481A Introduction of naked DNA or RNA encoding non-human vertebrate peptide hormones or cytokines into non-human vertebrate |
| 05/30/2001 | CN1297469A Process for extracting carotenes from carotene-contg. materials |
| 05/30/2001 | CN1297357A Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists |
| 05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |
| 05/30/2001 | CN1296851A Antivirus immune globulin for dog, fox and marten and its preparing process |
| 05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
| 05/29/2001 | US6239259 Multivalent and multispecific antigen-binding protein |
| 05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
| 05/29/2001 | US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
| 05/29/2001 | US6238937 Determining endpoint in etching processes using principal components analysis of optical emission spectra with thresholding |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | US6238890 Single chain forms of the glycoprotein hormone quartet |
| 05/29/2001 | US6238883 Neurotransmitter transporter SC6 |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells |
| 05/29/2001 | US6238872 Inhibiting restenosis by inserting stent that has antigen attached, then administering antibody labeled with radioactive source; immunotherapy |
| 05/29/2001 | US6238860 Amino acid sequence of polypeptide which binds b19-polypeptide; detection in sample; removal from solution; testing transfusion blood supplies |
| 05/29/2001 | US6238859 Virus protein antigens of the JC virus |
| 05/29/2001 | US6238676 Vaccine |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238667 Binding using an azidotrytophan compound |
| 05/29/2001 | US6238665 Anti-edema agent |
| 05/29/2001 | US6238664 Process for stabilizing proteins |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2171611C Analog of haemophilus hin47 with reduced protease activity |
| 05/29/2001 | CA2065292C Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 05/29/2001 | CA2025938C Cloning of the gene which codes for the pilinic subunit fim3 of bordetella pertussis |
| 05/25/2001 | WO2001036977A2 Identification of disease markers involving mass-based-separation |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/25/2001 | WO2001036656A2 A complex between hyaluronic acid and a biomolecule and its use |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036614A2 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036486A2 Scfv antibodies against disease associated molecules |
| 05/25/2001 | WO2001036485A2 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036473A2 Human g protein-coupled receptors |
| 05/25/2001 | WO2001036472A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036467A2 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | WO2001036461A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036456A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/25/2001 | WO2001036455A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036433A2 Synthetic lipid-a analogs and uses thereof |
| 05/25/2001 | WO2001036005A2 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | WO2001035994A2 Chitosan induced immunopotentiation |
| 05/25/2001 | WO2001035993A2 Compositions and methods for stimulating an immune response against infectious agents |
| 05/25/2001 | WO2001035992A1 Recombinant chlamydia vaccine |
| 05/25/2001 | WO2001035991A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 05/25/2001 | WO2001035990A2 Method for enhancing t cell reactivity toward tumour antigens |